Corrigendum: Therapeutic potential of topical administration of acriflavine against hypoxia-inducible factors for corneal fibrosis.
HIF
TGF-β1
corneal fibrosis
corneal hypoxia
extracellular matrix
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2023
2023
Historique:
received:
08
02
2023
accepted:
09
02
2023
entrez:
20
3
2023
pubmed:
21
3
2023
medline:
21
3
2023
Statut:
epublish
Résumé
[This corrects the article DOI: 10.3389/fphar.2022.996635.].
Identifiants
pubmed: 36937850
doi: 10.3389/fphar.2023.1161682
pii: 1161682
pmc: PMC10015497
doi:
Types de publication
Published Erratum
Langues
eng
Pagination
1161682Subventions
Organisme : NEI NIH HHS
ID : K08 EY031340
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY003790
Pays : United States
Commentaires et corrections
Type : ErratumFor
Informations de copyright
Copyright © 2023 Zhu, Shan, Li, Pan, Wang, Zhu, Guo, Mi, Wu, Yin and Pang.